Drugs / CTX
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01516593 | Nov 2011 → Apr 2013 | Burkitt lymphoma, HIV infectious disease | Andres J. M. Ferreri | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CTX | “CTX (dd 1) associated with rituximab on dd 3 and 10” NCT01516593 ↗ |